What payment methods are accepted?

We accept LC, T/T, D/P, PayPal, and small-amount payments.

Noiseless Low Temperature High Flow Air Compressor Portable Medical Oil Free Air Compressor

Name: Noiseless Low Temperature High Flow Air Compressor Portable Medical Oil Free Air Compressor
Brand: Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.
SKU: 1956959405

Jiangsu, ChinaSinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

US$62.00

1-999 Pieces

US$58.00

1,000-4,999 Pieces

US$55.00

5,000-9,999 Pieces

US$50.00

10,000+ Pieces

Sample price:US$65.00/piece.Request sample

Product profile

Customization

Available

Warranty

Two Years

Lubrication Style

Oil-free

Model NO.

GLE280A

Cooling System

Air Cooling

Brand Name

OEM

Voltage

220V 50Hz

Rated Air Flow Rate

≧75 L/Min @2 Bar

Air Capacity

75L/Min

Speed

1440rpm

Temperature

-5℃-40℃

Thermal Protector

135℃

Noise

≤52dB(a)

Rate Working Pressure

2 Bar

Power Source

AC Power, AC Power

Weight

6.0 Kg

Core Components

Engine, Motor

Working Pressure

2 Bar, 1.4 Bar Other

Transport Package

2 PCS / Carton Case 54 PCS / Pallet

Specification

235*101*163 mm

Origin

China

HS Code

8414804990

Production Capacity

500000 Piece/Year

Key features

Oil-Free Lubrication: Ensures pure air output suitable for medical and sensitive applications.

Compact Portable Design: Lightweight at 6.0kg with dimensions 235*101*163mm for easy transport.

Wide Voltage Compatibility: Supports 110V/220V at 50Hz/60Hz for global usage flexibility.

Comprehensive Warranty: Includes a 2-year warranty covering mechanical defects.

OEM Branding Support: Customizable brand name available for private label requirements.

Company profile

Sinc Gleeman Medical Technology(Changzhou) Co.,Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-06-11Nearest Port: ShanghaiAverage Response Time: ≤7.65hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CIF, DDP

AI-Powered supplier vetting

SummarySinc Gleeman Medical Technology (Changzhou) Co., Ltd. is identified as both a trading company and manufacturer/factory in China. The supplier reports substantial manufacturing infrastructure, including over 600 employees, a 61,000-square-meter facility, more than 10 production lines, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. It exports to multiple regions and holds ISO 9001 and ISO 14001 certifications. The supplier also states that it supports OEM/ODM partnerships. However, many operational, R&D, service, traceability, and contract-related fields remain unknown. An SGS audit is documented with a validity period from June 18, 2024 to June 17, 2025, but the provided audit result code is not interpretable as a substantive performance conclusion.

Supplier typeThe supplier is explicitly classified as both a Trading Company and Manufacturer/Factory. Its stated die-casting, motor production, CNC finishing, automatic assembly, and vertically integrated supply-chain operations support the presence of manufacturing capability rather than trading-only activity.

CertificationsThe supplier reports ISO 14001 and ISO 9001 certification. An SGS audit is also documented, with a stated validity period from 2024-06-18 to 2025-06-17; however, the supplied audit result value is not sufficiently explained to assess the audit outcome.

Production capacityProduction capability is supported by more than 10 production lines, over 600 employees, a 61,000-square-meter factory, full production facilities and testing instruments, vertical integration, and stated annual capacity of 4,000,000 oil-free air pumps. The supplier also reports 3,000,000 oxygen concentrator compressor pieces in annual output information.

Customization capabilityThe supplier explicitly states that it works with global intelligent product brand owners, retailers, and distributors to establish OEM/ODM partnerships. However, the dedicated OEM capability, ODM service availability, and related R&D service fields are otherwise marked unknown, so the evidence confirms stated partnership intent but not the full scope of customization execution.